-
September 15, 2023 The Biggest Psychedelic News Stories of the Week – September 11thCalifornia stands on the cusp of a psychedelic revolution with the TREAT Act and a...
-
August 29, 2023 Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health TreatmentAside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and...
-
June 21, 2023 Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?As an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised...
-
September 16, 2022 Adverse Events in Psychedelic Clinical Trials are UnderreportedNew research shows that enthusiasm for psychedelic treatments makes it easy to ignore adverse events...
-
August 9, 2022 Psychedelic Clinical Trials and the Michael Pollan EffectWith the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on...
-
August 8, 2022 Three Phase 3 Clinical Trials that Could Legalize PsychedelicsThe road to psychedelic legalization has many paths. These 3 clinical trials have the best...
-
July 27, 2022 3 Microdosing Clinical Trials to Keep an Eye OnDoes microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical...
-
June 17, 2022 Psychedelic Business Spotlight – June 17This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin...
